Lachman has been providing
both onsite and remote
support to our clients
for many years.

Review Support Offerings
The Lachman Difference

The most efficient services.
The most qualified professionals.

Since 1978, Lachman Consultants’ multidisciplinary team of highly experienced FDA consultants and industry experts has offered compliance, regulatory affairs, and science & technology services to clients around the world.

Learn More About Us

Stay in the know

Sign up today for the Lachman Consultants blog.

Get the latest news on industry compliance, regulatory affairs, technical services, and a whole lot more.

    Lachman Practice Groups

    Three Practices
    Executing One Vision

    Lachman Consultants maintains three practice groups: Compliance, Regulatory Affairs, and Science and Technology. Each practice offers industry-leading experience and expertise in its area of focus.

    Lachman OnCall Logo

    Get the answers and guidance to your most pressing questions faster than ever before.

    Now you can speak to one of our Subject Matter Experts and get the answers you need quickly on the many pressing issues arising in the life science areas that Lachman Consultants serves on a day to day basis. Whether it’s something you need to know about compliance, or a complex scientific or technical issue, Lachman OnCall™️ can provide you the timely information you require as needs arise and unforeseen questions occur.

    Learn More About Lachman OnCall

    OnCall Image

    Recent Posts

    The Lachman Consultants Blog

    The latest on industry compliance, regulatory affairs, technical services, and a whole lot more.

    Red Arrow Moving Down Over Graph Paper Background

    September 2021 ANDA Approval Actions Slow Through the First Half of the Month

    Through the last posting on the daily approval list on September 16, O...
    Read More

    Whoops, Lots of OTC Manufacturers Missed the Deadline – FDA Releases OTC Arrears List

    The FDA published its first arrears list for failure to pay FY 2021 Ov...
    Read More
    Waiting for the tide

    OGD Updates July 2021 Statistics

    It’s another month of full stats in the books, but not much to cheer...
    Read More
    Hanging word Q&A

    Q&A Guidance on Development of Generic Drugs During the COVID 19 Emergency

    Today, the FDA issued a guidance document titled Development of Abbrev...
    Read More
    Novel Photo

    Pilot Program for Novel Excipients Announced

    The use of novel excipients has potential to assist in the development...
    Read More

    OGD Updates June 2021 Metrics

    The metrics for June appear to be in line with those of other months t...
    Read More
    Contact Us Today